TradesViz
Hesitation kills trades. ⏱️ In a fast-moving market, you don't have time to think about how to place the order. You just need to act. Use the Trading Simulator to build muscle memory. Drill your hotkeys and mouse movements using the control panel on the right. 👉 Hit "Buy". 👉 Manage the trade. 👉 Hit "Flatten". Do it 100 times here so you don't freeze up when it counts.
TradesViz
Dissect the trade, don't just log it. 🩺 This is your post-game locker room. On the left, you have the hard data: MFE and MAE. On the right, you have the visual proof of your entry and exit timing. Did you sell too early? Did you hold through too much pain (high MAE)? The data doesn't lie. Use it to tighten your stops and extend your targets.
TradesViz
Some outliers are worth following. But you have to spend time with your journal. By that, we mean 3-4 clicks on TradesViz and maybe 2 minutes 😆 This is where your trading edge starts. Make sure you are on the right platform... 👇
TradesViz
Build the cage for your lizard brain. 🧠 In the heat of the moment, it’s easy to skip rules. A defined Trade Plan acts as your external discipline. How to Create: Define the hard rules. Is the "Price near VWAP"? Is the "Candlestick formation" valid? Set these up as mandatory inputs. How it Looks: A simple, distraction-free checklist. If you can't check the box, you shouldn't be in the trade. Bridge the gap between your plan and your execution.
TradesViz
History doesn't repeat, but it often rhymes. 🎶 Before you enter a trade, check the rhythm of the stock. The Seasonality Dashboard breaks down performance by Year, Quarter, and Month to reveal hidden cycles. Look at the "Seasonality vs Quarter" chart in this example: Period 1 (Q1) is a massive green tower, while Period 4 (Q4) is barely profitable. Why fight the current? If the last 10 years of data say "Long in Q1," put the probability on your side. Trade with the trend, not against it.
TradesViz
Momentum surged into Jan 22 across several small and mid‑caps as speculative buying returned in force. $AMCR stole the spotlight with a 366.8% gain over three sessions on nearly 10M shares traded, signaling aggressive short‑term accumulation despite a 52% pullback in volume from prior peaks. $SXTP and $CRVS followed with triple‑digit moves of 321% and 213%, supported by exceptional turnover — $CRVS alone saw volume explode 11,554% week‑over‑week. In biotech and health‑related names, $IVF, $CJMB, and $SPHL all posted near‑200% price jumps with parabolic volume growth, typical signatures of rapid speculative rotation. $IBRX maintained leadership on both lists, rising 115% in price alongside a 543% four‑day volume climb, confirming sustained institutional participation. Broadly, price acceleration matched with multi‑day volume persistence indicates strong market engagement at the micro‑cap level. This combination often precedes short‑term continuation but also signals an overheated tape demanding selective discipline.
TradesViz
Put‑to‑call ratios spiked into Jan 22, led by pronounced premium expansion across several key sectors. $MNDY and $XLI topped the list with astronomical four‑day increases of 34,260% and 30,374%, signaling aggressive downside hedging in both software and industrial exposures. $DIS and $MDB followed with notable jumps of 9,976% and 7,902%, as traders rushed to secure protection into late January. $C also showed a 3,941% build in its ratio, with the chart reflecting persistent put accumulation and price weakness through the period. Secondary moves in $AFRM, $ANET, and $CCL added to the defensive tilt, each posting multi‑hundred‑percent surges in premium. The pattern across these names points to broad portfolio‑level hedging, not isolated sentiment swings. When ratios climb this sharply across unrelated sectors, it often reflects tightening risk controls rather than directional bets.
TradesViz
Heavy premium hit the tape heading into Jan 22, led by sizable long‑dated flows across metals, tech, and AI names. $GLD opened the session with multiple large sweeps, including a $29M sell print at the $465 strike expiring Jan ’26 and additional legs totaling more than $40M — a clear sign of continued reallocation in gold exposure. $BIDU followed with back‑to‑back call splits on the Jan ’27 $125 and $130 strikes, combining for $57M in premium, pointing to deliberate accumulation in Chinese tech. $PLTR also printed a $25M split buy for March ’26 calls at the $50 strike, reinforcing persistent AI demand despite recent volatility. $INTC, $MU, and $NVDA rounded out the semiconductor flow with multiple mid‑ to long‑term contracts trading between $6M and $13M per leg. The balance of buy and sell flow suggests positioning adjustments rather than directional chases. Overall, the tape showed disciplined allocation into gold and tech, with traders extending duration out to 2027 — a sign of patient, conviction‑based positioning.
TradesViz
Earnings on Jan 22 center on large‑cap industrials, healthcare, and financials. $PG leads pre‑market with a $343B market cap and $1.87 EPS estimate, while $GE follows at $329B and $1.44 EPS, setting a heavy‑weight tone for the open. $COF, $HBAN, and $NTRS round out the morning financial slate, offering signals on credit, deposit, and lending sentiment. After hours feature $ISRG, $ABT, $FCX, and $CSX — a diverse mix cutting across medical devices, biotech, mining, and transportation, each with multi‑billion‑dollar caps and solid visibility into both consumer and industrial demand trends. Macro data is equally full: final GDP, jobless claims, and the Core PCE series all release between 07:30 and 09:00. With heavy corporate and economic catalysts aligned, Jan 22 stands as a pivotal day for both earnings tone and inflation read‑through.
TradesViz
One bad day doesn't make a bad trader. A bad week might. 🗓️ Day trading can be noisy. The Week View smooths out the daily variance so you can see the actual trend of your strategy. By grouping your data by week, you can ignore the noise of a random Tuesday loss and focus on the Total PnL trajectory. In this example, despite a few red weeks, the Total PnL column holds steady around $2,000 - $3,000. Judge your performance on a timeframe that actually matters.
